{"title": "GUIDANCE FOR CLINICAL TRIAL PROTOCOLS", "author": null, "url": "https://www.spirit-statement.org/", "hostname": "spirit-statement.org", "description": null, "sitename": "spirit-statement.org", "date": "2022-04-01", "cleaned_text": "SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) The [SPIRIT 2013 Statement ](https://www.spirit-statement.org/publications-downloads/)provides evidence-based recommendations for the minimum content of a clinical trial protocol. SPIRIT is [widely endorsed](https://www.spirit-statement.org/about-spirit/spirit-endorsement/) as an international standard for trial protocols. The recommendations are outlined in a [33-item checklist](https://www.spirit-statement.org/title/) and [figure](https://www.spirit-statement.org/schedule-of-enrolment-interventions-and-assessments/). Each checklist item is detailed in the [Explanation & Elaboration](https://www.spirit-statement.org/publications-downloads/) paper. Key Documents SEPTRE (SPIRIT Electronic Protocol Tool & Resource) is an innovative web-based tool that simplifies the creation, formatting, and registration of high-quality trial protocols. The SEPTRE protocol tool incorporates automation and the evidence-based SPIRIT guidance to strengthen the quality, efficiency, and transparency of clinical trials. Please [contact us](../../../../../../../septre-free-trial-request/) for a demo and further details. News & Updates [SPIRIT-Outcomes extension now available in JAMA to guide reporting of outcomes-related information in protocols](https://jamanetwork.com/journals/jama/fullarticle/2799547?resultClick=1)(December 2022) [SPIRIT-Path extension: protocol guidance for reporting cellular and molecular pathology content \u2014 Lancet Oncology (October 2021)](https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00344-2/fulltext) [SPIRIT-PRO explanation and elaboration paper published (July 2021)](https://bmjopen.bmj.com/content/11/6/e045105.full?ijkey=zWLUzMqY3h6aztD&keytype=ref) [CONSERVE Statement published in JAMA - guidance for trials modified by COVID-19 and other extenuating circumstances (June 2021)](https://jamanetwork.com/journals/jama/fullarticle/2781397) - - Japanese translations of [SPIRIT-PRO](http://lifescience.co.jp/yk/yk20/yke2010.html)and [CONSORT-PRO](http://lifescience.co.jp/yk/yk20/yke2011.html)published (January 2021) - [SPIRIT-AI guidance now published for trials of artificial intelligence interventions (September 2020)]( https://www.clinical-trials.ai ) - [SPIRIT extension for BMJ (February 2020)]( https://www.bmj.com/content/368/bmj.m122 ) - [SPIRIT-CONSORT Extension for clinical trials of intelligence interventions (September 2019)]( https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31819-7/fulltext ) - Web-based [SEPTRE clinical trial protocol now available (February 2019)]( https://www.spirit-statement.org/septre/) - [SPIRIT- TCM extension published for trials of medicine]( https://www.ncbi.nlm.nih.gov/pubmed/30484022)(January 2019) - [French Translation [by Cochrane France]](https://www.spirit-statement.org/wp-content/uploads/SPIRIT_2013_Statement_FR_final.pdf)(July 2018) - [Doug Altman, SPIRIT group executive member and legendary giant in improving the quality of research, will be greatly missed]( https://www.bmj.com/content/361/bmj.k2588) - [SPIRIT-PRO extension published in JAMA: Trial protocol guidance for patient-reported outcomes (February 2018)](https://www.spirit-statement.org/wp-content/uploads/jama_Calvert_2018_sc_170006.pdf ) "}